Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1993 Jun;12(2):73-82.
doi: 10.1007/BF00689802.

The experimental development of bioreductive drugs and their role in cancer therapy

Affiliations
Review

The experimental development of bioreductive drugs and their role in cancer therapy

P Workman et al. Cancer Metastasis Rev. 1993 Jun.

Abstract

Bioreductive drugs undergo metabolic reduction to generate cytotoxic metabolites. This process is facilitated by bioreductive enzymes and the lower oxygen conditions present in solid tumours compared to normal tissues. Because of this specificity, bioreductive drugs have enormous potential to contribute to modern cancer therapy. Examples undergoing clinical trials include N-oxides such as tirapazamine, aziridinylnitroimidazoles RSU 1069/RBU 6145 and quinones such as indoloquinone EO9. Other novel structures are also under study. Here we review the experimental development of bioreductive drugs and their role in cancer therapy.

PubMed Disclaimer

References

    1. Int J Radiat Oncol Biol Phys. 1984 Sep;10(9):1585-94 - PubMed
    1. Biochem Pharmacol. 1987 Mar 15;36(6):887-96 - PubMed
    1. Br J Cancer. 1981 Apr;43(4):546-50 - PubMed
    1. J Natl Cancer Inst. 1992 Feb 5;84(3):187-93 - PubMed
    1. Br J Cancer. 1984 May;49(5):579-85 - PubMed

LinkOut - more resources